- HEXO Corp (HEXO) flagship Masson-Angers cultivation campus received its CUMCS-GACP certification
- The Masson-Angers cultivation campus is a cannabis production facility in Quebec
- The CUMCS-GACP certification is compliant with the World Health Organization and European Medicines Agency Good Agricultural and Collection Practice guidelines
- HEXO Corp is an award-winning consumer packaged goods cannabis company
- HEXO Corp. opened trading at C$7.19 per share
HEXO Corp (HEXO) flagship Masson-Angers cultivation campus has received its Control Union Medical Cannabis Standard GACP (CUMCS-GACP) certification.
CUMCS-GACP is the leading certification standard for medical cannabis cultivation.
“Receiving the CUMCS-GACP certification is a testament to the team’s attention to detail and commitment to producing high-quality, consistent cannabis products to serve the global cannabis industry,” said Sebastien St-Louis, HEXO CEO and co-founder.
“As we continue to go after additional market share in Canada, and to penetrate new markets around the world, this certification demonstrates that we continue to offer high-quality output our current and future CPG partners can count on.”
The CUMCS-GACP certification represents a standard of quality and consistency for cannabis propagation, cultivation and post-harvest processes and is compliant with both the World Health Organization and European Medicines Agency Good Agricultural and Collection Practice guidelines.
HEXO Corp is an award-winning consumer packaged goods cannabis company that creates and distributes innovative products to serve the global cannabis market.
HEXO Corp. opened trading at C$7.19 per share.